also clearly observed a significant trend for HNSCC non-responders (treated with chemo-radiotherapy) to demonstrate PD-L1 expressing CTCs.
← all excerpts
Circulating Tumour Cell Expression of Immune Markers as Prognostic and Therapeutic Biomarkers in Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis.
1
—
—